Search bioRxiv⌕ Search

Biology subjects

Yoshikai, Y.

Publications and source records attributed to Yoshikai, Y..

2 recordsLinked to original sources

Distinct origin and fate for fetal hematopoietic progenitors

It was proposed that two sequential sources of intraembryonic multipotent progenitors ensure blood cell production from late gestation into adulthood, with only the latter producing self-renewing hematopoietic stem cells (HSC). How these two populations differ and how they impact the establishment of the postnatal immune system, remains poorly understood. Using complementary lineage tracing models, we showed that the first emerging embryonic multipotent progenitors (eMPP) are responsible for late gestation hematopoiesis. They are distinct from HSC that do not significantly contribute to embryonic mature blood cells. eMPP are the predominant source of embryonic lymphocytes and lymphoid tissue inducer cells, some of which persist for life. Between E12.5 and E16.5 eMPP rapidly differentiate, whereas HSC expand 20-fold. Altogether, these results support the notion that eMPP establish the embryonic adaptive immune system and shape the lymphoid organs where later adaptive immune responses occur, while HSC expand to sustain blood cell production throughout life.

developmental biology↗

Tyk2-mediated signaling promotes the development of autoreactive CD8+ CTLs and autoimmune type 1 diabetes

Tyrosine kinase 2 (TYK2), a member of the JAK family, might be a susceptibility gene for type 1 diabetes (T1D), whereas its precise role in autoimmune T1D remains unknown. We showed Tyk2 deficiency and inhibition suppressed autoimmune T1D development in non-obese diabetic (NOD) mice. Defective IL-12 signaling due to Tyk2 deficiency in islet-autoreactive CD8+ CTLs during their priming reduced T-bet expression, leading to impaired Cxcr3 expression and effector functions against {beta}-cells. Tyk2 deficient CD8+ resident dendritic cells (rDC) exhibited reduced MHC I expression and impaired cross-priming of CTLs. In {beta}-cells, increased expressions of Fas, MHC I, and chemokines with age were attenuated by Tyk2 deficiency. We demonstrated that treatment with BMS-986165, a Tyk2 inhibitor, inhibited the development of CTLs and inflammation in {beta}-cells in vitro. BMS-986165 reduced the incidence of diabetes in NOD mice. Thus, we demonstrated that Tyk2-mediated signaling has a critical role in the development of autoreactive CD8+ CTLs, inflammation in {beta}-cells, and the pathogenesis of autoimmune T1D. SummaryWe demonstrated that Tyk2-mediated signaling plays a critical role in the development of autoreactive CD8+ CTLs, inflammation in {beta}-cells, and the pathogenesis of autoimmune T1D. These findings will lead to the development of safety and effective prevention strategies for T1D.

immunology↗